A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
Penny K. Sneed(University of California, San Francisco), Minesh P. Mehta(Columbia University), Seema Sanghavi(University of Wisconsin–Madison), Vernon King(Albany Medical Center Hospital), John M. Buatti(University of Iowa), Paul W. Sperduto(Methodist Hospital), Richard J. Chappell(University of Wisconsin–Madison), William F. Regine(University of Kentucky), John H. Suh(Cleveland Clinic), John C. Breneman(University of Cincinnati), Steven J. Goetsch(San Diego Cardiac Center), Eduardo Weltman(Hospital Israelita Albert Einstein)
International Journal of Radiation Oncology*Biology*Physics
July 1, 2002
Cited by 508
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k